1 / 8

J Kjekshus, et al. NEJM 2007;357:Epub

The CORONA Study: Characteristics of the Patients* Part I.

ferrol
Download Presentation

J Kjekshus, et al. NEJM 2007;357:Epub

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The CORONA Study:Characteristics of the Patients* Part I * Plus–minus values are means ±SD. The bodymass index is the weight in kilograms divided by the square of the height in meters. To convert the values for cholesterol to milligrams per deciliter, divide by 0.02586. To convert the values for triglycerides to milligrams per deciliter, divide by 0.01129. To convert the values for creatinine to milligrams per deciliter, divide by 88.4. CABG denotes coronaryartery bypass grafting, PCI percutaneous coronary intervention, Apo apolipoprotein, GFR glomerular filtration rate estimated with use of the modified diet in renal disease equation, NTproBNP Nterminal pro–Btype natriuretic peptide, hsCRP highsensitivity Creactive protein, ACE angiotensinconverting enzyme, and ARB angiotensinreceptor blocker.† Measurements were performed in 1820 patients in the placebo group and 1844 patients in the rosuvastatin group.‡ This category includes thiazidelike diuretics. J Kjekshus, et al. NEJM 2007;357:Epub

  2. The CORONA Study:Characteristics of the Patients* Part II * Plus–minus values are means ±SD. The bodymass index is the weight in kilograms divided by the square of the height in meters. To convert the values for cholesterol to milligrams per deciliter, divide by 0.02586. To convert the values for triglycerides to milligrams per deciliter, divide by 0.01129. To convert the values for creatinine to milligrams per deciliter, divide by 88.4. CABG denotes coronaryartery bypass grafting, PCI percutaneous coronary intervention, Apo apolipoprotein, GFR glomerular filtration rate estimated with use of the modified diet in renal disease equation, NTproBNP Nterminal pro–Btype natriuretic peptide, hsCRP highsensitivity Creactive protein, ACE angiotensinconverting enzyme, and ARB angiotensinreceptor blocker.† Measurements were performed in 1820 patients in the placebo group and 1844 patients in the rosuvastatin group.‡ This category includes thiazidelike diuretics. J Kjekshus, et al. NEJM 2007;357:Epub

  3. The CORONA Study: Kaplan–Meier Estimates for the Primary Outcome, Death from Any Cause, and Any Coronary Event John Kjekshus, et al. N Engl J Med 2007;357:Epub

  4. The CORONA Study: Prespecified Composite Cardiovascular Outcomes and Fatal and Nonfatal Events – Part I John Kjekshus, et al. N Engl J Med 2007;357:Epub

  5. The CORONA Study: Prespecified Composite Cardiovascular Outcomes and Fatal and Nonfatal Events – Part II John Kjekshus, et al. N Engl J Med 2007;357:Epub

  6. The CORONA Study: Primary Outcome in Subgroups of Patients with Prespecified Risks J Kjekshus, et al. NEJM 2007;357:Epub

  7. The CORONA Study: Patients Who Had at Least One Hospitalization and the Total Number of Hospitalizations* John Kjekshus, et al. N Engl J Med 2007;357:Epub

  8. The CORONA Study: Side Effects and Adverse Events* John Kjekshus, et al. N Engl J Med 2007;357:Epub

More Related